Selected References (for a complete list, click here)

Osterrieder, N., Neubauer, A., Brandmüller, C., Kaaden, O.-R. and O'Callaghan, D.J. (1996). The equine herpesvirus 1 (EHV-1) IR6 protein influcences virus growth at elevated temperatures and is a major determinant of virulence. Virology 226, 243-251.

Schumacher, D., Tischer, B.K., Fuchs, W. and Osterrieder, N. (2000). Reconstitution of Marek's Disease Virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome (BAC) and characterization of a glycoprotein B-negative MDV-1 mutant. Journal of Virology 74:11088-11098.

Tischer, B.K., von Einem, J., Kaufer, B., and Osterrieder N. (2006). Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40: 191-196.

Osterrieder, N., Kamil, J.P., Schumacher, D., Tischer, B.K., and Trapp, S. (2006). Marek’s disease – From Miasma to Model. Nature Reviews Microbiology 4: 283-294.

Goodman, L.B. Wagner, B., Flaminio, M.F., Sussman, K.H., Metzger, S.M., Holland, R., and Osterrieder, N. (2006). Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 24, 3636-3645.

Trapp, S., Kamil, J.P., Schumacher, D., Nair, V.K., Parcells, M.S., and Osterrieder, N. (2006). A Virus-Encoded Telomerase RNA Promotes Malignant T-Cell Transformation. The Journal of Experimental Medicine 203, 1307-1317.